FDA Advisory Panel Votes For Northera For A Second Time This week, an FDA advisory panel voted 16-1 in favor of Northera, a drug manufactured by Chelsea Therapeutics and used to treat Neurogenic Orthostatic Hypotension NOH - a rare form of low blood pressure. The disease is associated with neurological disorders including Parkinson’s disease and affects the patient only when they are in a standing position.
Jan. 22, 2014 - BioresearchOnline